EMBASE and SciSearch revealed no economic analyses of any drug treatment in CIU; consequently, there were no studies showing the health economic impact of daily levocetirizine treatment in adults ...

Sales of Xyzal in the first half of 2008 were $227 million ... is comparable to other major chronic diseases. In addition, a drug development presence in allergic rhinitis has strategic value ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

Dec 23 (Reuters) - The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' (HIK.L), opens new tab generic version of Novo Nordisk's diabetes drug (NOVOb.CO), opens new tab ...

Inflammatory and sensory skin disorders are significantly affected by stress and emotion. Griesemer (1978), who was both a dermatologist and a psychiatrist, developed an index of the effect of ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...

Telangana DCA conducts raids and seize counterfeit versions of Montek-LC tablets of Sun Pharma: Peethaambaran Kunnathoor Chennai Saturday, January 4, 2025, 08:00 Hrs [IST] Acting ...